Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00109876. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Study identification
- NCT ID
- NCT00109876
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Alliance for Clinical Trials in Oncology
- Other
- Enrollment
- 54 participants
Conditions and interventions
Conditions
Interventions
- Computed Tomography-Guided Optical Sensor-Guided Radiofrequency Ablation Procedure
Procedure
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2006
- Primary completion
- Jul 31, 2012
- Completion
- Jan 31, 2013
- Last update posted
- Mar 7, 2017
2006 – 2013
United States locations
- U.S. sites
- 17
- U.S. states
- 14
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UAB Comprehensive Cancer Center | Birmingham | Alabama | 35294 | — |
| Jonsson Comprehensive Cancer Center at UCLA | Los Angeles | California | 90095-1781 | — |
| University of California Davis Cancer Center | Sacramento | California | 95817 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Boston University Cancer Research Center | Boston | Massachusetts | 02118 | — |
| William Beaumont Hospital - Royal Oak Campus | Royal Oak | Michigan | 48073 | — |
| Stony Brook University Cancer Center | Stony Brook | New York | 11794-9446 | — |
| Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill | Chapel Hill | North Carolina | 27599-7295 | — |
| Good Samaritan Hospital Cancer Treatment Center | Cincinnati | Ohio | 45220 | — |
| Providence Cancer Center at Providence Portland Medical Center | Portland | Oregon | 97213-2967 | — |
| Rhode Island Hospital Comprehensive Cancer Center | Providence | Rhode Island | 02903 | — |
| H. Clay Evans Johnson Cancer Center at Memorial Hospital | Chattanooga | Tennessee | 37404 | — |
| Medical City Dallas Hospital | Dallas | Texas | 75230 | — |
| Huntsman Cancer Institute at University of Utah | Salt Lake City | Utah | 84112 | — |
| Providence Cancer Center at Sacred Heart Medical Center | Spokane | Washington | 99204 | — |
| Providence Cancer Center at Holy Family Hospital | Spokane | Washington | 99207 | — |
| Medical College of Wisconsin Cancer Center | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00109876, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 7, 2017 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00109876 live on ClinicalTrials.gov.